CAChristopher J. Anderson

Christopher J. Anderson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christopher J. Anderson has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nuclear adaptation to intracellular mechanical forces regulates the phagocytic capacity of Drosophila macrophages in vivo

    by Clelia Amato, Rosina Graham, Rosalind Heron, Sebastian Rogatti, Christopher J. Anderson, Stephen J. Jenkins, Will Wood

    How macrophages fine-tune their appetite to fulfil their clearance role is incompletely understood. Phagocytosis exacerbates cytoplasmic crowding, but whether macrophages can sense this increase and use it to regulate their phagocytic capacity has never been investigated. Here, we test the hypothesis that phagosomes exert a strain on the nucleus, which in turn responds to the intracellular mechanical inputs influencing macrophage appetite. Combining genetic manipulation and live in vivo imaging, we show that engulfed apoptotic bodies indent and deform the nucleus of Drosophila embryonic macrophages, and that phagocytosis increases Lamin B levels. Importantly, we show that silencing Lamin B or components of the LINC complex negatively regulates apoptotic body engulfment in vivo. Thus, we demonstrate that phagosome-induced nuclear molecular and mechanical adaptations are critical for Drosophila embryonic macrophages to sustain apoptotic corpse uptake, thereby unveiling a role for nuclear plasticity in the regulation of macrophage phagocytic capacity in vivo.

  • Open Access

    Intestinal bacteria hijack an evolutionarily conserved epithelial repair signal

    by Sam Benson, Priscilla Chin, Sebastian Rogatti, Alessandro Scopelliti, Luigi Zechini, Rosalind Heron, Charlotte Dawson, Anna Davey, Mariska Simpson, Amanda O. Wong, et al.

    Apoptosis in the gut triggers an expansion in the Enterobacteriaceae family of bacteria, causing both prolonged tissue injury and delayed repair. However, the mechanisms linking the Enterobacteriaceae bloom and subsequent deleterious tissue response are relatively unknown. Here, we establish purines as a major component of the apoptotic secretome that are consumed by bacteria. Explicitly, we identify hypoxanthine as a critical metabolite that is taken up and metabolised by both pathogenic and commensal species within the Enterobacteriaceae family. Epithelial cells release hypoxanthine into the extracellular space during early stages of apoptosis via the upregulation of equilibrative nucleoside transporters 1/2 (ENT1/2). Critically, beyond simply linking host and microbe, we delineate a connection between the release of hypoxanthine from the dying cell and the ability of the host to repair damaged epithelial tissue. Hypoxanthine is a potent promoter of epithelial cell repair in both gut and skin across the phylogenetic tree including humans, mice, zebrafish, and fruit flies and promotes similar ATP production and cellular proliferation in eukaryotic and microbial recipients. Thus, the preferential utilisation of hypoxanthine by the Enterobacteriaceae directly competes with the host for a core reparative signal.

  • Open Access

    CD163 and Tim-4 identify resident intestinal macrophages that are spatially regulated by TGF-β

    by Vignesh Jayaraman, Ian E. Prise, Verena Kästele, Sabrina Tamburrano, Kelly Wemyss, Hayley M. Bridgeman, Rufus H. Daw, Patrick Strangward, Alfie Sanderson, Sheena M. Cruickshank, et al.

    Macrophages localize in sub-tissular niches associated with their ontogeny and activity. In the intestine, a paradigm has emerged that long-lived macrophages are present in the muscular layer, while highly monocyte-replenished populations are found in the lamina propria (LP). Whether long-lived macrophages are restricted in such a simplified manner has not been well explored. Moreover, the impact of specific gut-associated factors on macrophage identity across intestinal tissue layers is unknown. We generated scRNA-seq data from WT and Ccr2−/− mice to identify phenotypic features of long-lived macrophage populations in distinct intestinal layers and identified CD163 as a marker to distinguish submucosal/muscularis (S/M) from LP macrophages. Challenging the emerging paradigm, long-lived macrophages were found in the LP and S/M, with distinct transcriptomes and responsiveness to proinflammatory stimuli. Employing transgenic mice, we demonstrate a critical role for TGF-β signalling in maintaining the identity of long-lived LP but not S/M macrophages and that macrophage-derived TGF-β1 is required to instruct intestinal macrophage identity after development.


  • Open Access

    Dead but not gone: the interplay between the programmed cell death process and surrounding bacteria

    by Sam Benson, Christopher J. Anderson

    Cell death is an integral part of homeostasis, removing damaged and infected cells and replenishing healthy cells. It is a process well understood from a host perspective, with clearly delineated pathways and an expansive literature as to how it interacts with other immune and tissue mechanisms. However, the interaction between cell death and the microbial community is less well explored. There is an understanding of how bacterial pathogens are able to induce death and can have a detrimental impact on tissue resolution and repair but little on how bacteria respond to homeostatic cell death or death caused by non-bacterial stimuli. This review will cover recent advances in the understanding of host-microbe communication during cell death and will discuss how bacteria modulate/are modulated by cell death-related phenomena. The interplay between the microbiota and the fundamental processes involved in host cell death presents an exciting opportunity to discover how modulation of host mechanisms can beneficially modulate the microbiota, and therefore concurrently offer potential routes to control a number of conditions that have been linked to aberrant microbiota composition, including inflammatory bowel disease and cancer.


  • Open Access

    Dynamic changes to the intestinal environment occur throughout recovery from experimental ischemic stroke

    by Rachel M L Martin, Isobel C Mouat, Robert J Whelan, Lizi M Hegarty, Lizzie F R Blunt, Christopher J Anderson, David H Dockrell, Calum C Bain, Gwo-Tzer Ho, Laura McCulloch

    Stroke survivors can experience a plethora of complications throughout their recovery that impair quality of life and impact neurological outcomes. Intestinal dysfunction is reported to occur rapidly following stroke in both humans and animal models and alterations such as reduced barrier integrity, lymphocyte loss and an altered microbiota have been suggested to contribute to increased brain injury. Despite the persistence of gastrointestinal symptoms in many stroke survivors, how the intestinal environment changes over the course of stroke recovery remains poorly understood. Here, we use an experimental model of ischaemic stroke to determine if gastrointestinal dysfunction persists into chronic recovery. We have shown that experimental stroke leads to structural alterations to the colon, a thinned mucus barrier, impaired transit times and an altered bacterial community composition. While barrier function and transit times recover within 2 weeks, structural and bacterial community alterations remain up to 3 months after stroke and are accompanied by altered luminal antibody profiles. Together, this suggests that the gastrointestinal system is dynamically altered over the course of experimental stroke recovery and highlight intestinal dysfunction as a target to improve patient outcomes beyond the acute recovery window.


  • Cell Death and Infection: Implications for Host and Microbe

    by Anna Davey, Thibaut Sanchez, Christopher D. Lucas, Christopher J. Anderson

    Cell death is a part of life. Every day, billions of cells undergo programmed cell death within the human body as part of normal tissue turnover and homeostasis. The factors that initiate programmed cell death, the resulting signalling pathways that occur within the dying cell, the means to dispose of the dying cell, and the response of the neighbouring tissue to the dying cell are all highly evolutionarily conserved and tightly regulated processes. Decades of outstanding research have identified critical components of programmed cell death initiation, corpse clearance, and tissue response, particularly in the context of homeostatic cell death or sterile injury-induced cell death; however, multiple tissues are not sterile under homeostasis. In particular, the intestinal and respiratory tracts are ‘external environment-facing’ tissues that are in constant contact with commensal microorganisms and are also frequently exposed to invading pathogenic microbes. Indeed, many pathogenic microbes are capable of inducing or inhibiting various forms of cell death during infection, and some go as far as to utilise the metabolites released to the environment during apoptosis for their own growth. The primary emphasis of the field has been on the identification of what form of programmed cell death is initiated during infection and what the immunological consequences are. In contrast, less is known about how the critical stages of cell death and cell clearance directly or indirectly impact the microbes (both commensal and pathogenic) themselves. In this review, we will pay particular attention to the host cell-cell communication events occurring downstream of programmed cell death and highlight new research and new questions surrounding how these fundamental host processes interact with the bacterial communities, with a particular focus on the intestine and the lung.

  • Open Access

    DYNAMIC CHANGES TO THE INTESTINAL ENVIRONMENT OCCUR THROUGHOUT RECOVERY FROM EXPERIMENTAL ISCHAEMIC STROKE

    by Rachel M. L. Martin, Isobel C. Mouat, Robert Whelan, Lizi M. Hegarty, Christopher J. Anderson, David H. Dockrell, Calum C. Bain, Gwo-Tzer Ho, Laura McCulloch

    Stroke survivors experience a plethora of complications during recovery, including gastrointestinal symptoms. Intestinal dysfunction is reported to occur rapidly following stroke in both humans and animal models and alterations such as reduced barrier integrity, lymphocyte loss, and an altered microbiota have been suggested to contribute to poor neurological outcomes. Despite the persistence of gastrointestinal symptoms in many stroke survivors, how the intestinal environment changes over the course of stroke recovery remains poorly understood. Here, we use an experimental model of ischemic stroke to profile the gastrointestinal tract over a three month period of recovery.We have shown that experimental stroke leads to structural alterations to the colon, impaired transit times and an altered bacterial community composition. No impairments to barrier function were detected at any time point and transit times recover within 2 weeks post stroke. In contrast, structural and bacterial community alterations remain up to 3 months post stroke and are accompanied by abnormalities that develop only during chronic recovery, such as altered antibody coating of bacteria. These results suggest that the gastrointestinal system is dynamically altered over the course of experimental stroke recovery and that certain defects persist chronically after stroke.


  • Open Access

    New insights on an old friend: AroA linked to iron-dependent outer membrane stability

    by Priscilla Chin, Christopher J. Anderson

    Salmonella is a common causative agent of infectious intestinal and systemic disease and has been extensively studied for several decades. Yet, much of Salmonella pathogenicity remains a mystery due in part to the highly complex virulence and adaptation strategies at the pathogen’s disposal. One of the more influential tools within the field, an attenuated aroA- deficient Salmonella strain, has been used for many years to probe the host immune response that would otherwise be impossible with a fully virulent strain. Now, new work by Rooke et al. (J. L. Rooke, E. C. A. Goodall, K. Pullela, R. Da Costa, et al., mBio 15:e03319-23, 2024, https://doi.org/10.1128/mbio.03319-23 ) utilizes in-depth transposon-directed insertion-site sequencing to elucidate the contribution of genes to Salmonella fitness within isogenic wild-type and aroA -deficient strains. Specifically, Rooke et al. demonstrate that the deletion of the aroA gene leads to iron-dependent membrane instability, raising several exciting new ideas surrounding Salmonella biology and therapeutic strategies.


  • Open Access

    Broad-spectrum antibiotics disrupt homeostatic efferocytosis

    by Pedro H. V. Saavedra, Alissa J. Trzeciak, Allie Lipshutz, Andrew W. Daman, Anya J. O’nEal, Zong-Lin Liu, Zhaoquan Wang, Jesús E. Romero-Pichardo, Waleska Saitz Rojas, Giulia Zago, et al.

    The clearance of apoptotic cells, termed efferocytosis, is essential for tissue homeostasis and prevention of autoimmunity1. Although past studies have elucidated local molecular signals that regulate homeostatic efferocytosis in a tissue2,3, whether signals arising distally also regulate homeostatic efferocytosis remains elusive. Here, we show that large peritoneal macrophage (LPM) display impairs efferocytosis in broad-spectrum antibiotics (ABX)-treated, vancomycin-treated and germ-free mice in vivo, all of which have a depleted gut microbiota. Mechanistically, the microbiota-derived short-chain fatty acid butyrate directly boosts efferocytosis efficiency and capacity in mouse and human macrophages, and rescues ABX-induced LPM efferocytosis defects in vivo. Bulk messenger RNA sequencing of butyrate-treated macrophages in vitro and single-cell messenger RNA sequencing of LPMs isolated from ABX-treated and butyrate-rescued mice reveals regulation of efferocytosis-supportive transcriptional programmes. Specifically, we find that the efferocytosis receptor T cell immunoglobulin and mucin domain containing 4 (TIM-4, Timd4) is downregulated in LPMs of ABX-treated mice but rescued by oral butyrate. We show that TIM-4 is required for the butyrate-induced enhancement of LPM efferocytosis capacity and that LPM efferocytosis is impaired beyond withdrawal of ABX. ABX-treated mice exhibit significantly worse disease in a mouse model of lupus. Our results demonstrate that homeostatic efferocytosis relies on distal metabolic signals and suggest that defective homeostatic efferocytosis may explain the link between ABX use and inflammatory disease4,5,6,7.


  • Microbes exploit death-induced nutrient release by gut epithelial cells

    by Christopher J. Anderson, Christopher B. Medina, Brady J. Barron, Laura Karvelyte, Tania Løve Aaes, Irina Lambertz, Justin S. A. Perry, Parul Mehrotra, Amanda Gonçalves, Kelly Lemeire, et al.

    Regulated cell death is an integral part of life, and has broad effects on organism development and homeostasis1. Malfunctions within the regulated cell death process, including the clearance of dying cells, can manifest in diverse pathologies throughout various tissues including the gastrointestinal tract2. A long appreciated, yet elusively defined relationship exists between cell death and gastrointestinal pathologies with an underlying microbial component3,4,5,6, but the direct effect of dying mammalian cells on bacterial growth is unclear. Here we advance a concept that several Enterobacteriaceae, including patient-derived clinical isolates, have an efficient growth strategy to exploit soluble factors that are released from dying gut epithelial cells. Mammalian nutrients released after caspase-3/7-dependent apoptosis boosts the growth of multiple Enterobacteriaceae and is observed using primary mouse colonic tissue, mouse and human cell lines, several apoptotic triggers, and in conventional as well as germ-free mice in vivo. The mammalian cell death nutrients induce a core transcriptional response in pathogenic Salmonella, and we identify the pyruvate formate-lyase-encoding pflB gene as a key driver of bacterial colonization in three contexts: a foodborne infection model, a TNF- and A20-dependent cell death model, and a chemotherapy-induced mucositis model. These findings introduce a new layer to the complex host–pathogen interaction, in which death-induced nutrient release acts as a source of fuel for intestinal bacteria, with implications for gut inflammation and cytotoxic chemotherapy treatment.